Arrowhead Research | ARWR - Pe Kurs-Gewinn

Aktienkurs
72.87
Täglich Wechseln
2.34 3.32%
Monatlich
16.22%
Jährlich
419.02%
Q2 Prognose
72.33




Pe Veränderung Datum
Agios Pharmaceuticals 3.56 0 2026-03
Alnylam Pharmaceuticals 170.7 367.33 2025-12
Anika Therapeutics 47.54 27.2 2024-06
Incyte 15.35 0.51 2026-03
Ionis Pharmaceuticals 396.15 79.28 2022-09
Ligand Pharmaceuticals 60.65 17.62 2025-09
Merck 13.92 5.08 2025-12
Moderna 27.22 14.51 2023-06
Novartis 20.17 2.32 2026-03
Sarepta Therapeutics 27.27 0 2025-09
TG Therapeutics 10.76 2.32 2025-12
Vertex Pharmaceuticals 26.15 2.22 2025-12
Xencor 29.92 3.22 2022-09